SCHEMBL7981252

SCHEMBL7981252

CNc1ccc2c(nc(N)c3cncn32)c1-c1c(C)cccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983694 0.89 LCK (0.56) LCK
SCHEMBL7983715 0.87 LCK (0.46) LCK
SCHEMBL7969763 0.86 LCK (0.53) LCK
SCHEMBL7981784 0.85 LCK (0.44) LCK
SCHEMBL7982713 0.84 LCK (0.51) LCK
SCHEMBL7981130 0.83 LCK (0.52) LCK
SCHEMBL7983254 0.82 LCK (0.42) LCK
SCHEMBL7982931 0.82 LCK (0.49) LCK
SCHEMBL7983218 0.81 LCK (0.49) LCK
SCHEMBL7969625 0.81 LCK (0.41) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed